Skip to content

Comparison of dexmedetomidine and remifentanil in improving recovery after minimally invasive surgery under propofol anesthesia.

Comparative study of dexmedetomidine infusion vs remifentanil infusion as an adjuvants to propofol-based anaesthesia on post operative recovery in minimally invasive surgery: a randomized controlled study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/110032
Enrollment
130
Registered
2026-05-04
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Dexmedetomidine: dexmedetomidine infusion at a dose of 0.5 mcg/kg/hour will be administered as an adjuvant to propofol based anaesthesia during minimally invasive surgery. Propofol infu

Sponsors

Mahatma Gandhi Medical College And Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age 18 65 years All genders ASA Grade I and II Undergoing elective minimally invasive surgery.

Exclusion criteria

Exclusion criteria: Severe cardiovascular, renal, or hepatic disease. Chronic opioid or sedative use. BMI more than 35 kg/m . Any illness that prevents investigators to ask the QoR questions like neurological, psychological diseases 5. Pregnant or lactating female.

Design outcomes

Primary

MeasureTime frame
quality of postoperative recovery assessed using QoR-15 score on postoperative day 1Timepoint: quality of postoperative recovery assessed using QoR-15 score on postoperative day 1

Secondary

MeasureTime frame
Postoperative pain intensity assessed using Visual Analogue Scale (VAs)Timepoint: At 1, 6, 12 and 24 hours postoperatively ;Changes in heart rate and mean arterial pressure during intraoperative periodTimepoint: aseline, intraoperatively at 1 , 3 , 5 , 10 , 15 minutes and then regularly at 15 minutes interval ;Time to achieve Aldrete score more than 9 after discontinuation of infusion Timepoint: From switching off infusion until achievement of Aldrete score more than 9 in the postoperative period;Level of sedation assessed using Ramsay Sedation ScoreTimepoint: Intraoperatively and in the immediate postoperative period ;Total postoperative rescue analgesic requirement in first 24 hours Timepoint: Within 24 hours postoperatively ;Incidence of adverse effects such as hypotension, bradycardia, respiratory depression, nausea and vomitingTimepoint: Intraoperative and within 24 hours postoperatively;Total propofol requirement during surgeryTimepoint: From induction to completion of surgery;Time to first ambulation postoperativelyTimepoint: From end of surgry to first ambulation;Time to extubation after discontinuation of anaesthetic agentsTimepoint: From stopping anaesthetic agents to tracheal extubation

Countries

India

Contacts

Public ContactDr vijay mathur

Mahatma Gandhi Medical College And Hospital

drvijaymathur@mgumst.org9829191038

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026